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Simple Summary: The use of phytogenic products has entered mainstream use in the livestock
industry as an antibiotic alternative. These products, often based on herbs and spices with established
antimicrobial properties, are generally considered as safe and natural, however, they are often
administered in high doses and frequency. The direct effects of these products on the livestock
animals remains under-reported. Using a transcriptomics, we show that supplementing 2% oregano
in feed has direct effects on gene expression in the livers of broilers with a potential range of beneficial
and negative side effects.
Abstract: Pathogen control is re-emerging as a significant challenge to the health of both humans
and animals. The livestock industry is in the process of massively replacing in-feed antibiotics with
organic production friendly plant-based products. Nutrigenomics as a science of the effects of food
constituents on gene expression is shedding more light on both benefits and detrimental side-effects
of feed additive prolonged consumption on the host, indicating the need to understand the feed-host
interactions and their influence on the host disease profile. In this study, we investigated the effects of
2% oregano powder supplementation on the liver gene expression in healthy male broilers from the
hatch to 6 weeks of age. Deep RNAseq was performed on average 113.3 million paired and quality
trimmed sequences per sample and four samples for the control and treatment each. The results
demonstrate the severity of oregano effect on liver gene expression with substantial modifications in
steroid hormone regulation, fat and carbohydrate metabolism alterations and strong influence on the
host disease and function profile. Oregano supplementation was able to interfere with the transcrip-
tional effects of a range of registered drugs and to significantly transcriptionally inhibit a range of
cancer disease categories including liver cancer, and to modify fat and carbohydrate metabolism.
Keywords: liver; RNAseq; oregano; broiler; steroid hormones; cancer
1. Introduction
Antibiotic growth promoters (AGPs) are used in the livestock industry to prevent
both host and zoonotic disease, control microbial populations and promote the growth of
animals [1]. Most economically significant diseases controlled by AGPs are necrotic enteritis
(NE) and Salmonella [2]. The term “growth promotion” by antibiotic addition refers to
increased animal growth in terms of weight gain on the same amount of feed consumed [3],
and it is often misleadingly confused in the media as growth hormone supplementation.
The growth-promoting action of supplemented AGPs to livestock feed is attributed
to the reduction of the immune response caused by lack of pathogen pressure. The meat
of animals fed AGPs has a higher protein and lower fat percentage [3]. In the industry
characterized with high pathogen load and high stocking density, pathogen control in
combination with good biosecurity lowered morbidity, morality and inflammation and
increased farm productivity [3].
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Recently, concerns about livestock industry harboring antimicrobial resistance genes
that can be transferred to humans resulted in the trend of banning the AGPs as livestock
supplement worldwide. Rise in the antimicrobial resistance (AMR) is a process where
bacteria are becoming resistant to antibiotics expected to kill them. AMR is now recognized
by the World Health Organization (WHO) as a priority research area with dire predictions
that the death toll of AMR could be one person every three seconds, amounting to 10 million
per year by 2050 and costing the world over USD 100 trillion [4].
Initially, the ban of AGP use was perceived as a total disaster by the shell-shocked
livestock industry as the disease soared on the farms in the countries that banned AGPs
first [5]. Nevertheless, the industry quickly adjusted and made a move towards alternative
natural pathogen controlling agents like well-known antimicrobial herbs and spices such
as oregano, thyme, garlic, capsicum, cinnamon, and others [6]. Initially, this started as
a raw spice or essential oil supplementation, but over the last decade, it evolved to the
use of products with controlled doses of the most active antimicrobial components from
the herbs and spice origin [7]. Regardless of the large-scale use by industry, very little is
known about how products with such a complex mode of action affect different organs
and physiological systems as well as general animal health and wellbeing.
The Lamiaceae family, including mint, sage, thyme, marjoram, and oregano, are one
of the most widely used natural products for their potent and efficient antimicrobial
characteristics. Origanum vulgare (oregano) has been widely studied as a phytoadditive.
Oregano essential oil generally contains monoterpenes carvacrol and thymol and their
biosynthetic precursors p-cymene and y-terpinene have been shown to be the dominant
components [8,9]. Carvacrol and thymol, separately, have antimicrobial effects against
bacteria and fungi and when used together, show an additive effect against pathogens [10].
Oregano and its active components are among the most highly used in the poultry industry
for pathogen control due to excellent antimicrobial action against major economically
important poultry pathogens [7].
Nutritional genomics, also called nutrigenomics, is a rapidly emerging area of science
investigating the effects of food formulations or individual food constituents on gene
expression and host health [11]. Nutrigenomics opened the horizons for the use of per-
sonalized nutrition in patient recovery, disease prevention and treatment. Personalized
nutrition in athletes can help optimize body composition and athletic performance [12].
In veterinary nutrition, welfare and performance of farmed, wild and pet animals can ben-
efit from nutrigenomic studies. Many diets and food constituents are holding information
on their potential use in health and wellbeing as well as possible adverse effects they may
have on the host. At the moment, the high sequencing cost is the primary limiting factor
for the projected immense growth and applications of nutrigenomics.
Presently there is only one transcriptomic study on the effects of oregano supplemen-
tation [13], curiously in broiler chicken liver gene expression. Sabino et al. [13] reported
inhibition of fatty acid metabolism and insulin signaling pathways in broilers supplemented
with oregano extract. They suggested that oregano plays a role in reducing abdominal and
visceral fat deposition and that dietary oregano could present an intervention opportunity
in obesity and diabetes. Others have also investigated the effects of oregano and other
herbal extracts on gene expression using qPCR or ELISA to gain the insight to change
of selected target genes [14–16]. We hypothesized that high level of continual oregano
consumption would have a strong influence on liver gene expression that would exceed
previously reported alterations due to cumulative effects of prolonged use, and would
likely alter bird predisposition to different types of disease.
In this manuscript, we present the transcriptional effects of prolonged oregano use on
the gene expression in the liver of broiler chickens fed powdered oregano from the hatch
to 6 weeks of age. Our results indicate complex interactions of oregano components with
the host transcriptional regulation, androgen hormones, cancer-related disease, fat and
carbohydrate metabolism and are relevant for both veterinary and medical use.
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2. Materials and Methods
2.1. Oregano and Feed Preparation
Dried Turkish oregano (Saucy Spice Company, NSW) was used to prepare the powder
for the feed. The particle size of oregano with highest antimicrobial action against Salmonella
was previously determined [17] and oregano powder was processed in a Planetary Ball Mill
Machine (speed no. 5, 2 h, 40 g*each run; Changsha Yonglekang Equipment, China) and the
dried powder passed through a 75 µm sieve. The particle size of the oregano powder
used in feed, determined by laser diffraction (Mastersizer 2000, Malvern, ATA scientific,
Taren Point, Australia) had an average diameter of 10 µm.
Chicken diet formulated to meet or exceed the National Research Council guide-
lines for broiler chickens, commercially produced by Red Hen, (Laucke Mills, Australia).
Red Hen broiler chicken ration is a blend of whole and rolled grains and micro pellets,
certified drug free with no antimicrobials or coccidiostats. The feed contained the following
ingredients: wheat, triticale, barley, oats, peas, lupins, lentils, beans, canola, soybean,
sunflower, meatmeal, fish meal, blood meal, fat, molasses, limestone, di-calcium phosphate,
sodium bicarbonate, potassium carbonate, salt, lysine, methionine, threonine, tryptophan.
Vitamins supplemented include A, D3, E, K, thiamine (B1), riboflavin (B2), pantothenate
(B5), pyridoxine (B6), B12, niacin, folic acid, biotin, and choline. Minerals supplemented in
the ration were calcium, phosphorus, potassium, sodium, chloride, cobalt, copper, iron,
iodine, manganese, molybdenum, selenium, and zinc. Final macronutrient content was
20% protein, 5% fat, 6.5% fiber, and 0.35% fat. The oregano was mixed into the feed at
2% (w/w).
2.2. Characterization of Oregano
The proportion of powdered oregano used as a feed additive in the trial was sent
to ChemCentre analytical lab (Perth, Australia) operating as an Australian Government
facility (www.chemcentre.wa.gov.au (accessed on 16 November 2020)). Total phenolics and
terpenes were determined using the Folin–Ciocalteu method as described and analyzed
on GS-MS (GC system—Agilent 7890A GC system connected to an Agilent 5977A MSD;
Agilent Technologies, Santa Clara, CA, United States) using method described by Singleton
et al. [18] and Phenomenex column—Zebron ZB-1MS, 60 m × 0.32 mm × 1.00 µm. Total di-
etary fiber was determined using the Megazyme total dietary fiber assay procedure as per
the detailed protocol published by a supplier [19].
2.3. Birds and Management
Day old Ross Broiler 308 chicks (Bond Enterprises, Toowoomba, Australia) were ran-
domly distributed into two groups (n = 12 chicks/treatment) in temperature and light
controlled room. All birds were fed ad libitum and had unrestricted access to drinking
water. Birds were individually tagged using leg bands and weighed every week for a
total of 42 days. Birds were euthanized at day 42 post-hatch (CO2, BOC, North Ryde,
Australia) and dissected. Liver sections were taken from all birds for histology and RNA
extraction. Four male birds were randomly selected from each treatment for RNAseq
analysis. For each bird one cut was made from the same section of the liver and split into
two cuts, one for histology and the other for RNAseq.
2.4. Histology
The tissue samples of liver were collected and fixed in 10% buffered formalin so-
lution. Fixation, paraffin embedding, deparaffinization, rehydration, and staining with
hematoxylin and eosin (H&E), were done by routine laboratory procedures. Glass slides
were scanned at the Translational Research Institute Microscopy Core Facility (Brisbane,
Australia) using a Nikon Brightfield, Olympus VS120 slide scanner (Olympus, Tokyo,
Japan) and analyzed using Olympus microscopy software Olyvia (Olympus, Tokyo, Japan).
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2.5. RNAseq Sequencing
About 100 mg of tissue samples were homogenized with 1 mL of TRIsure (Cat# BIO-
38033, Bioline Meridian Bioscience, London, UK) using OMNI tissue homogenizer TH
(OMNI International, Kennesaw, GA, USA) and centrifuged, followed by a phase separation
adding 200 µL of chloroform and centrifugation. The RNA from the resulting aqueous
phase was isolated and cleaned up using Bioline Isolate II RNA Mini Kit (Cat# BIO-52072)
following the manufacturer’s instructions. Extracted RNA was sent to the sequencing
facility in RNAstable tubes. The sequencing was performed in Macrogen, Inc., Korea.
The library was prepared using TruSeq RNA Library Prep Kit v2 #RS-122-2001 (Illumina,
San Diego, CA, United States), and sequenced on Novaseq 600 150 bp PE. Four samples
were successfully extracted and sequenced from each control and oregano treatment liver
with a total of eight sequenced samples. Sequencing data is available on the Sequence Read
Archive (SRA) database (https://www.ncbi.nlm.nih.gov/sra (accessed on 16 November
2020).) under BioProject accession number PRJNA683135.
2.6. Data Analysis, Software and Statistics
CLC Genomics Workbench by Qiagen Bioinformatics was used for RNAseq anal-
ysis. Quality trimmed sequences and detailed sequencing quality QC file is given in
Table S1. Paired sequences were assigned to genes and transcripts against chicken genome
(Gallus_gallus-5.0), using CLC Genomics Workbench recommended settings. Resulting raw
matrix was used in DeSeq2 analysis to provide differential expression and fold change
for each gene. DeSeq2 was done in R and the output was imported to Qiagen’s Ingenuity
Pathway Analysis (IPA) software where the remaining analysis was performed using the
IPA significance cut-offs as indicated in the results section.
3. Results
3.1. Animals and Trial
We translated the oregano concentration to phenolics and terpenes using chemical analysis.
In dried powdered oregano, concentrations of 3-carene, alpha-pinene, alpha-terpinene, alpha-
terpineol, beta-pinene, caryophyllene, citronellal, citronellol, eucalyptol, gamma-terpinene,
geraniol, geraniol acetate, limonene, myrcene, p-cymene, terpine-4-ol, terpinolene were all
under the detection limit. Linalool and thymol were both present at 0.01% (w/w), and, as ex-
pected, carvacrol dominated with 0.84% (w/w) of dried oregano. Total polyphenols in oregano
were 37.8 g/kg of powdered oregano, making it 756 mg/kg in finished feed. Powdered
oregano contained 52.6% total dietary fiber (final of 1.05% in finished feed). Thus final concen-
trations of oregano phytogenic products in chicken feed were 0.0168% carvacrol, and 0.0002%
of thymol and linalool each.
There was no difference in any of the health parameters (weight, mortality, feed intake)
between oregano supplemented and control birds. This experiment focused on transcrip-
tomics and molecular effects and was not investigating feed conversion ratio (FCR) or other
performance measures to reduce the animal number as per the animal reduction ethics
principles. The birds’ weights exceeded AVIAGEN recommended Ross Broiler 308 industry
standard. More details on animal weights, feed consumption, microbiota composition,
short-chain fatty acids, and multiple organ histology on this dataset can be found in
Bauer et al. [17].
Comparison of liver histology between the control and oregano supplemented birds
showed no visible changes in liver pathology or function (Figure S1).
3.2. Sequencing Quality Control
This dataset was sequenced remarkably deep, aiming to over 100 million paired
sequences per sample, with a total number of paired, quality trimmed sequences for eight
samples sequenced of 906,494,608 with average 113,311,826 paired and quality trimmed
sequences per sample. Sequences were paired and quality trimmed to zero ambiguous,
length of all sequences of 150–151 nt, and minimum PHRED score of 20, with 97.73% of
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sequences with PHRED > 30. A detailed sequencing QC file for each sample is given
in Table S1.
3.3. Liver Gene Expression
There were 14,247 genes with transcripts detected as expressed in the liver in our
study; Table S2 contains raw gene data matrix, as well as “Counts Per Million” (CPM),
“Transcripts Per Million”(TPM) and “Reads Per Kilobase of transcripts per Million mapped
reads” (RPKM) normalized data against the chicken genome annotations, while Table S3
provides DeSeq2 analysis outputs with log2 FC, P-values and FDR corrected statistics.
Among the known and annotated genes most highly upregulated in the liver by oregano
are CACNG4, TEKT5, COL20A1, ALDH1L2, ADGRG7, OTOS, COL10A1 and ANKRD22,
while the most downregulated known genes included FGF19, RASGRF2, GUCY2C, RERG,
MFAP3L, TACR1, CTSEAL, VTG2, CTNNA3, SMAD7B, UBAP2, SPIN1W, HNRNPKL,
and NIPBLL.
3.4. Pathway Analysis
The Qiagen’s Ingenuity Pathway Analysis (IPA) analysis is based on the comprehen-
sive, 9.6 million manually curated gene expression annotations, in the Ingenuity Knowl-
edge Base (IKB) commercial database (Qiagen, 2020, Hilden, Germany). IPA uses IKB
database to identify the most significant pathways affected by treatment and discover
potential novel regulators, networks and connections associated with selected gene lists.
IPA was able to map 11,101 out of 14,247 mapped chicken genes to IKB database, remaining
genes were unknown and had no annotations. We performed IPA analysis of the genes
differentially expressed with DeSeq2 p < 0.05 and with fold change cut-off between the
groups of 1.2 or equivalent of a minimum 20% increase or decrease of DeSeq2 significantly
differential genes.
There were 33 pathways significantly inhibited and five pathways activated in the
liver by oregano, as shown in Table S4. By far the most significant by the p-value and z-score
was aldosterone signaling in epithelial cells (Figure 1), with 19 genes from this pathway
among differentially expressed in liver between oregano and control samples: HSP90AA1,
HSP90AB1, HSPA2, HSPA5, HSPA8, HSPD1, HSPH1, DNAJA1, DNAJB5, DNAJC12, DNAJC6,
ITPR3, KRAS, NR3C2, PIKFYVE, PLCB1, PRKCE, PRKCI, and SCNN1B. Please note that IPA
pathway (Figure 1) does not show or color the expression of all individual genes involved
in the pathway, but rather it colors inhibited arms of the pathway green and activated as
red. Inhibition, in this case (Figure 1), can result from upregulation of genes that inhibit or
from downregulation of the genes that enhance the pathway.
3.5. Upstream Regulators
We proceeded with the IPA Upstream Analysis to predict upstream transcriptional
regulators that can explain the observed gene expression in the liver between oregano sup-
plemented and control fed birds. IPA’s definition of the upstream transcriptional regulator
is extensive and includes any molecule that can affect gene expression, from transcription
factors to micro RNA, enzymes, chemicals, or registered drugs. It is important to note
that the database will report any compound including other species transcription factors,
if there is evidence in IKB dataset that they could regulate the genes from our submit-
ted query list. For that reason, Table S5 provides full data, including a fold change of
transcription factors to indicate their presence/absence in our dataset.
IPA analysis predicted 19 molecules or other complex products that, based on literature
annotated in IKB database, can regulate differential genes in the same way as oregano and
thus get their effects amplified if used or, in case of transcription factors, activated together.
They included drugs geldanamycin, cephaloridine and tanespimycin; two toxic chemicals 2-
amino-1-methyl-6-phenylimidazo-4-5-b-pyridine, and 6-hydroxydopamine; CD3 complex,
enzymes KRAS, and KDM1A; G-protein coupled receptor CNR1; MTOR kinase, three micro
RNAs miR-34a-5p (and other miRNAs w/seed GGCAGUG), miR-1-3p (and other miRNAs
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w/seed GGAAUGU) and mir-210; five transcription regulators HSF1, RUNX1, STAT6,
PML, PAX5, and a transmembrane receptor TLR9 (noting that in chicken TLR21 acts as a
functional homologue to mammalian TLR9, and would be activated instead). Out of the
regulators above, MTOR, KRAS, PML, PAX5, and KDM1A were expressed in our dataset.




Figure 1. Aldosterone signaling pathway most significantly affected by oregano with 19 genes. Oregano significantly in-
hibited pathways included, IGF-1 Signaling, PI3K Signaling in B Lymphocytes, CREB Signaling in Neurons, Gαq Signal-
ing, Thrombin Signaling, Production of Nitric Oxide and Reactive Oxygen Species in Macrophages, Synaptic Long Term 
Depression, IL-3 Signaling, LPS-stimulated MAPK Signaling, CCR3 Signaling in Eosinophils, α-Adrenergic Signaling, 
Growth Hormone Signaling, Melatonin Signaling, Pancreatic Adenocarcinoma Signaling, Apelin Endothelial Signaling 
Pathway, Th1 Pathway, IL-6 Signaling, with full pathway list and statistics provided in Table S4. Activated pathways were 
Colanic Acid Building Blocks Biosynthesis, BAG2 Signaling Pathway, LPS/IL-1 Mediated Inhibition of RXR Function, An-
tioxidant Action of Vitamin C, and PTEN Signaling, as in Table S4. 
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The analysis reported 23 predicted inhibited regulators, molecules that, based on ex-
isting literature, can regulate genes in the opposite way to oregano, thus inhibiting each-
Figure 1. Aldosterone signaling pathway most significantly affected by oregano with 19 genes. Oregano significantly
inhibited pathways included, IGF-1 Signaling, PI3K Signaling in B Lymphocytes, CREB Signaling in Neurons, Gαq Signaling,
Thrombin Signalin , Production of Nitric Oxide and Reactive Oxygen Species in Macrophages, Synaptic Long Term
Depression, IL-3 Signaling, LPS-stimulated MAPK Signaling, CCR3 Signaling in Eos ophils, α-Adrenergic i ,
Gro th Hormone Signaling, Melatonin Signaling, Pancreatic Adenocarcinoma Signaling, Apelin Endothelial Signaling
Pathway, Th1 Pathway, IL-6 Signaling, with full pathway list and statistics provided in Table S4. Activated pathways were
Colanic Acid Building Blocks Biosynthesis, BAG2 Signaling Pathway, LPS/IL-1 Mediated Inhibition of RXR Function,
Antioxidant Action of Vitamin C, and PTEN Signaling, as in Table S4.
The analysis reported 23 predicted inhibited regulators, molecules that, b sed on exist-
in literature, can regulate genes in the opposit way to oregano, thus inhi iting ach-others
transcriptional action: two ndogenous chemicals aldosterone and dihydrotest sterone;
five chemical drugs BMS-690514, sirolimus, metformin, resveratrol, and cocai e; two chem-
icals SAHM1 and forskolin, genes encoding different cellular proteins TRAP1, NR3C1,
CD24, PTEN, SGPP2; transcription regulators HDAC5, NEUROG3, GLI1, SIM1, HNF4A,
EP300, ARNT2, FOXO3, and a transmembrane receptor CAV1.
The most inhibited upstream regulator was dihydrotestosterone (p = 8.95 × 10−5,
z-score = −3.162, Figure 2). There were 29 genes regulated by dihydrotestosterone among
our differential genes, 26 were expressed consistently with inhibition of dihydrotestosterone
(opposite to the action of dihydrotestosterone; Figure 2). All predicted upstream regulators,
with their fold change in our dataset, corresponding IPA statistics and target genes from
our differential DeSeq2 list, are given in Table S5.
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Figure 2. Predicted inhibition of the dihydrotestosterone (DHT) transcriptional regulation. Yellow lines
indicate that the direction f gen expression does not agree with predicted in ibition; grey line indicates
inconsistent literature on activation/inhibition of the gene by the regulator. Blue line indicates that if the
DHT is inhibited the gene should be downregulated (green). Red line indicates that if DHT is inhibited
the gene is expected to be upregulated (red).
We also investigated synergistic regulator effects looking for m ltiple regulators that
are either activated or inhibited to potentially regulate diseases or functions synergistically.
The upstream regulators CAV1, EP300, NR3C1, PTEN, MTOR, and PML were expressed
in our dataset, activated or inhibited in the direction that could lead to inhibition of
Development of Liver Tumor disease category, one of the significantly affected disease
categories; p = 5.55 × 10−6 (Figure 3).
3.6. Diseases and Functions
We next used IPA’s Diseases and Functions analysis that is comparable to typical gene
ontology analysis. This analysis compares the query list of differentially expressed genes
with the genes associated with specific diseases and functions based on annotations from
IKB database. There were three categories that were significantly increased: Peripheral
Vascular Disease, Urination Disorder and Cerebrovascular Dysfunction; 12 significantly
inhibited functions and diseases: Incidence of Tumor, Frequency of Tumor, Tumorigenesis
of Epithelial Neoplasm, Development of Malignant Tumor, Development of Carcinoma,
Development of Digestive Organ Tumor, Transport of Molecule, Development of Liver
Tumor, Cell Viability of Breast Cancer Cell Lines, Invasion of Epithelial Cell Lines, Quantity
of Neurons, and Oxidation of Lipid (Figure 4).
Separately, the upstream analysis identified one transcription regulator, Hepatocyte
Nuclear Factor 4 alpha, HNF4A, that was expressed as downregulated in our dataset and
identified as an inhibited transcription factor capable of affecting 7 of the 16 genes from the
Oxidation of Lipid category. Deeper inspection of all significantly altered subcategories
from Lipid Metabolism category indicated that highest contributor to overall category
inhibition comes from inhibition of Quantity of Steroid Hormone (p = 6.07 × 10−6, z = −1.92)
and Fatty Acid Metabolism (p = 1.9 × 10−4, z = −1.39).
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There was a range of significantly affected diseases by p-value, with activation/
inhibition based on z-score that can be observed on the Diseases and Functions heatmap
in Figure S3 and the full list of ise ses and functions with p-values and z-scores given
in Table S6.
There were 281 cancer-related categories significantly altered by oregano with zero
categories with z-score higher than 1 that would indicate disease activation, and 33 can-
cer categori s with z-score lower than −1 indicating disease inhibition, and a p-value
ranging from 4.6 × 10−4 to 1.4 × 10−17. Those inhibited cancer disease categories in-
clude Development of Liver Tumor, Tumorigenesis of Epithelial Neoplasm, Development
of Digestive Organ Tumor, Development of Hepatocellular Carcinoma, Head and Neck
Cancer, Skin Cancer, B Cell Cancer, Development of Lung Tumor, Abdominal Neoplasm,
Lymphoreticular Neoplasm, Urinary Tract Tumor, and others listed in Table S6.
Among the functions significantly affected by oregano supplementation, were eight
categories from carbohydrate and 13 from lipid metabolism all highly significantly al-
tered (p = 7.67 × 10−4 to 1.26 × 10−8). Based on z-scores, functions inhibited by oregano
were Metabolism of Carbohydrate, Synthesis of Carbohydrate, Uptake of Monosaccharide,
Glycolysis of Tumor Cell Lines, Uptake of 2-Deoxyglucose, and Uptake of D-glucose in
Carbohydrate Metabolism category. In Lipid Metabolism category inhibited functions were
Quantity of Steroid Hormone, Fatty Acid Metabolism, Quantity of Steroid, Quantity of
Polyunsaturated Fatty Acids, Conversion of Lipid, Metabolism of Acylglycerol, and Con-
centration of Lipid (Table S6). It should be noted that there is a strong overlap of genes
between the lipid and carbohydrate metabolism categories. Figure 5 shows an overlapping
network of interactions between carbohydrate and lipid metabolism.
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for inhibition. Red lines indicate activation, blue lines inhibition, grey lines inconsistent findings,
and yellow line indicates that the state of the gene is opposite from the literature based prediction.
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gene expression does not agree with literature; grey line indicates inconsistent literature on activa-
tion/inhibition of the gene by the regulator. Blue line indicates expected inhibition and red line
indicates expected activ tion.
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Accumulatively, the number of the significantly affected and slightly activated or
inhibited diseases, taken together, give a clear pattern of the oregano influence. Toxicology
functional analysis in IPA inspected organ toxicity of oregano supplementation (Table S7).
Based on liver gene expression, Development of Liver Tumor category, was significantly
(p = 3.25 × 10−5) decreased (z = −2.39), with 13 genes altered in the direction opposite
from liver tumor development pattern.
4. Discussion
Oregano is one of the most commonly used natural products in poultry production.
Despite its “natural” status, our results have shown that oregano is a complex compound
with diverse biological effects with implications not only in poultry but also in human
health. Continual prolonged consumption of oregano resulted in a range of changes
to the liver gene expression in broilers with most prominent effects being inhibition of
steroid hormones, fat and carbohydrate metabolism, and a number of cancer disease
categories (Figure 6).




Figure 6. An overview of the main effects of prolonged oregano consumption on liver transcriptomics. 
Aldosterone Signaling in Epithelial Cells is the most inhibited pathway in the liver of 
the birds fed oregano continuously for 6 weeks. Aldosterone is the primary mineralocor-
ticoid steroid hormone produced by the adrenal gland. It is essential for sodium conser-
vation in the kidney, salivary glands, sweat glands, and in the colon and plays a central 
role in the regulation of blood pressure, sodium and potassium levels [20]. Aldosterone 
production and signaling are disrupted in obesity [21]. Aldosterone dysregulation is path-
ologic and linked to cardiovascular and kidney disease. Low levels of aldosterone result 
in lowered blood pressure, an increase of potassium levels and lethargy, however, it 
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Figure 6. An overview of the main effects of prolonged oregano consumption on liver transcriptomics.
Aldosterone Signaling in Epithelial Cells is the most inhibited pathway in the liver of the
birds fed oregano continuously for 6 weeks. Aldosterone is the primary mineralocorticoid
steroid hormone produced by the adrenal gland. It is essential for sodium conservation in the
kidney, salivary glands, sweat glands, and in the colon and plays a central role in the regulation
of blood pressure, sodium and potassium levels [20]. Aldosterone production and signaling are
disrupted in obesity [21]. Aldosterone dysregulation is pathologic and linked to cardiovascular
and kidney disease. Low levels of aldosterone result in lowered blood pressure, an increase of
potassium levels and lethargy, however, it should be noted that inhibited aldosterone signaling
does not necessarily mean reduced aldosterone production or circulating blood levels. A major
mode of action of aldosterone is via modifying gene expression [20] by repressing and inducing
many genes.
In the liver, the aldosterone level is increased in liver fibrosis [22] and can increase
the levels of liver fat consistently enough to be used as a predictor of liver fat levels [23].
Aldosterone is also involved in the pathogenesis of the fatty liver disease [24] and in the
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pathogenesis of obesity and overweight [25,26]. Fat metabolism and oxidation were also in-
hibited in our dataset (Figure 4) and reduction of the fat oxidation category is likely partially
controlled by the inhibited and downregulated HNF4A—hepatocyte nuclear factor 4 alpha
transcription factor (Figure 4). This is consistent with findings of Sabino et al. [13] who also
investigated liver transcriptomics in broiler chickens fed oregano extract. They also re-
ported significant downregulation of genes involved in fatty acid metabolism in addition to
the insulin signaling pathway, which was not observed in our study. Whether the transcrip-
tional reduction of aldosterone signaling pathway has any connection with reduced levels
of aldosterone and resulting actual liver fat levels is still to be established. The overlap of
genes between the fat metabolism subcategories should be noted, and this effect on liver
fat metabolism could be largely due to effects on steroid arm of fat metabolism.
There was a range of significantly inhibited pathways that are related to aldosterone
signaling: Renin-Angiotensin Signaling, α-Adrenergic Signaling, and Growth Hormone
Signaling. In addition to altered pathways, aldosterone as well as dihydrotestosterone were
among the inhibited transcriptional regulators, i.e., oregano supplementation significantly
reversed their gene expression effects. Dihydrotestosterone is an androgen hormone,
made through the conversion of testosterone [27]. Almost 10% of the testosterone produced
by an adult person is converted in the testes and prostate, or in the ovaries in women,
to dihydrotestosterone [27]. Dihydrotestosterone is much more potent than testosterone,
and many of the testosterone actions occur after it is converted to dihydrotestosterone.
We have previously reported functional analysis of the microbiota genetic potential [28]
showing that 2% oregano in feed significantly reduced the abundance of intestinal bacterial
genes involved in steroid hormone biosynthesis via Picrust functional prediction [28], we con-
firmed this with ileum transcriptomics, and now also in the liver. Others have shown that
oregano can induce estrogenic responses in vitro and can also show estrogen-like activity [29],
thus influencing steroid hormone balance. This may be beneficial as the means to help regulate
steroid hormone-based imbalances, especially if the effects could be pinned to individual
components of oregano which is necessary for reproducibility of the outcome.
In addition to oregano’s effect of key metabolic and steroidal pathways, our data
also suggest that it may also influence the functioning of several commercially available
drugs or supplements. Forskolin, listed in IKB as a chemical toxicant is produced by the
roots of the Indian plant Coleus forskohlii and has been used for centuries in traditional
medicine, with safety recognized in modern medicine. Forskolin directly activates the
adenylate cyclase enzyme, that generates cAMP from ATP, and consequently, raising
intracellular cAMP levels [30]. This feature of forskolin is beneficial against cancers [31,32]
and recently synthesis of novel forskolin derivates for anticancer drug development and
suggestions for higher use as an anticancer drug ensued [33,34]. Forskolin is marketed as
a weight loss pill, also backed up by research [35]. In the liver, forskolin can significantly
diminish liver fibrosis acting as an antioxidant and anti-inflammatory agent via inhibition
of hedgehog signaling, mediated by cAMP-dependent activation of PKA [36]. Oregano
significantly changed the expression of 31 genes from the group of genes regulated by
forskolin, with only 3 of the 31 genes inconsistent with the inhibition (reversal) of forskolin
transcriptional profile.
Prolonged use of oregano also inhibited transcriptional pathways mediated by Sirolimus,
an anticancer agent and immunosuppressant mTOR inhibitor, marketed as Rapamune and
Rapamycin. It is used to coat coronary stents [37], prevent organ transplant rejection, especially
for kidney transplantation [38,39] and treat vascular anomalies [40] and a rare lung disease
called lymphangioleiomyomatosis [41]. IKB database lists 1508 clinical trials investigating the
role of Sirolimus in 424 medical conditions including a range of cancers and immunological
conditions as well as Crohn’s disease, range of kidney disorders, liver disease, coronary disease,
atherosclerosis, and more.
Another drug with alleged anticancer action whose effects on gene expression are
significantly reversed by oregano is resveratrol, a natural phenol produced by some plants
in response to injury or infection. Resveratrol is commonly used as a dietary supplement
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and studied as a potential treatment in many human diseases. IKB reports 70 clinical
trials on 40 conditions including polycystic ovary syndrome, knee osteoarthritis, infertility
condition, insulin resistance, schizophrenia, metabolic syndrome X, spastic paraplegia,
diabetes mellitus, Alzheimer’s disease, Friedreich ataxia, Parkinson’s disease, memory,
stage III colon cancer, stage II colon cancer, colon cancer, cancer, rectum cancer, colon ade-
nocarcinoma, colorectal tumor, adult solid tumor, hepatitis B, vascular injury, hepatitis,
ophthalmic disorder, disorder of lipid metabolism, and others.
The effects of resveratrol on cancer have been extensively studied, but they gave highly
inconsistent findings even at high doses used [42]; similarly, there is contradicting evidence
on its role in diabetes, cardiovascular health, and neurological disease [43]. However,
there is evidence that resveratrol improves lifespan and reduces aging [44] and can limit
secondary damage after ischemic stroke or acute brain trauma [45].
Oregano also significantly reversed the transcriptional effects of the anticancer drug
BMS-690514 (a VEGFR and EGFR tyrosine kinase inhibitor), cocaine, and also of metformin,
a drug used for the treatment of type 2 diabetes and of polycystic ovary syndrome. Possible
interference of prolonged oregano use on the range of drugs that have such wide effects
on the diseases and physiological functions makes the predictions of oregano enabled
final modifications of the liver function very challenging. Based on ileum gene expression
oregano also inhibited the effects of the contraceptive pill. At the same time, oregano may
amplify the effects of the geldanamycin, antitumor, antibiotic, and geldanamycin and its
derivate tanespimycin, as well as a semisynthetic derivative of cephalosporin C named
Cephaloridine and changes the expression and regulation of genes involved in a range
of diseases.
The upstream regulators CAV1, EP300, NR3C1, PTEN, MTOR, and PML were ex-
pressed in the direction that could lead to inhibition of Development of Liver Tumor
category. While this combination of genes may lead to the inhibition of liver cancer de-
velopment, changes to individual genes, such as the inhibition of the tumor suppressor
gene Phosphatase and tensin homologue deleted on chromosome 10 (PTEN) may have the
potential to increase the development of other neoplasms. PTEN acts on the phosphoinosi-
tide 3-kinase (PI3K)-AKT-mammalian target of rapamycin (mTOR) pathway and is one
of the most commonly disrupted tumor suppressors in human cancer [46]. Its inhibition
or loss is considered a founder genetic event for the induction and progression of tumor
development [47]. Natural products that have the potential to affect this important tumor
suppressor gene should be further evaluated.
We have recently reported the transcriptomic changes in the ileum of the same
birds [48]. While the effects on steroid hormones and rearrangement of cancer category
were consistent, in the ileum, we noted the inhibition of brain-gut axes signaling, a strong
reduction of goblet cells, and intestinal inflammation in oregano supplemented birds.
This suggests the importance of transcriptomic evaluation of multiple organs to elucidate
the effects of nutritional supplements in nutrigenomic studies.
Despite the inhibition of transcriptional effects of many antitumor drugs and sup-
plements and transcriptional regulators, our disease and function analysis suggest that
oregano use may also lead to inhibition of the range of tumors including liver tumor and
to possible enhancement of peripheral vascular disease, urination disorder, and cerebrovas-
cular dysfunction.
5. Conclusions
The results of this study have pointed to the biologically diverse effects of oregano
on gene expression, outside of its intended antimicrobial purpose. Whilst most of the
affected functions have little or no relevance for the use of phytogenic products in the
poultry industry, as chickens do not take any of the affected drugs and, at least during the
production lifespan, are not bothered with cancer or hormonal imbalance, it does highlight
potential unintended consequences of the prolonged use of natural products and may
have broader implications in both animal and human health. To eventually exploit the
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effects of oregano for clinical use in both supplemented livestock and humans, individual
compounds need to be investigated to isolate those responsible for the clinically useful
features of oregano and potential side-effects evaluated.
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